22
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals.

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Quantifying latently infected cells is critical to evaluate the efficacy of therapeutic strategies aimed at reducing the size of the long-lived viral reservoir, but the low frequency of these cells makes this very challenging.

          Related collections

          Most cited references50

          • Record: found
          • Abstract: found
          • Article: not found

          Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

          The hypothesis that quiescent CD4+ T lymphocytes carrying proviral DNA provide a reservoir for human immunodeficiency virus-type 1 (HIV-1) in patients on highly active antiretroviral therapy (HAART) was examined. In a study of 22 patients successfully treated with HAART for up to 30 months, replication-competent virus was routinely recovered from resting CD4+ T lymphocytes. The frequency of resting CD4+ T cells harboring latent HIV-1 was low, 0.2 to 16.4 per 10(6) cells, and, in cross-sectional analysis, did not decrease with increasing time on therapy. The recovered viruses generally did not show mutations associated with resistance to the relevant antiretroviral drugs. This reservoir of nonevolving latent virus in resting CD4+ T cells should be considered in deciding whether to terminate treatment in patients who respond to HAART.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.

            Treatment of infected patients with ABT-538, an inhibitor of the protease of human immunodeficiency virus type 1 (HIV-1), causes plasma HIV-1 levels to decrease exponentially (mean half-life, 2.1 +/- 0.4 days) and CD4 lymphocyte counts to rise substantially. Minimum estimates of HIV-1 production and clearance and of CD4 lymphocyte turnover indicate that replication of HIV-1 in vivo is continuous and highly productive, driving the rapid turnover of CD4 lymphocytes.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.

              The capacity of HIV-1 to establish latent infection of CD4+ T cells may allow viral persistence despite immune responses and antiretroviral therapy. Measurements of infectious virus and viral RNA in plasma and of infectious virus, viral DNA and viral messenger RNA species in infected cells all suggest that HIV-1 replication continues throughout the course of infection. Uncertainty remains over what fraction of CD4+ T cells are infected and whether there are latent reservoirs for the virus. We show here that during the asymptomatic phase of infection there is an extremely low total body load of latently infected resting CD4+ T cells with replication-competent integrated provirus (<10(7) cells). The most prevalent form of HIV-1 DNA in resting and activated CD4+ T cells is a full-length, linear, unintegrated form that is not replication competent. The infection progresses even though at any given time in the lymphoid tissues integrated HIV-1 DNA is present in only a minute fraction of the susceptible populations, including resting and activated CD4+ T cells and macrophages.
                Bookmark

                Author and article information

                Journal
                EBioMedicine
                EBioMedicine
                Elsevier BV
                2352-3964
                2352-3964
                Aug 2015
                : 2
                : 8
                Affiliations
                [1 ] Vaccine and Gene Therapy Institute Florida, Port St. Lucie, FL, USA.
                [2 ] University of California San Diego, La Jolla, California and Veterans Affairs San Diego Healthcare System, San Diego, CA, USA.
                [3 ] Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
                [4 ] Centre for Virus Research, Westmead Millennium Institute, Westmead, Australia ; Sydney Medical School, University of Sydney, Sydney, Australia.
                [5 ] Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
                [6 ] Infectious Disease, Merck Research Laboratories, West Point, PA, USA.
                Article
                S2352-3964(15)30048-7
                10.1016/j.ebiom.2015.06.019
                4563128
                26425694
                e94428e8-1d2f-4340-b42c-6aa654a87273
                History

                Eradication,HIV,Inducible virus,Latency,Multiply spliced RNA,Reservoir,TILDA

                Comments

                Comment on this article